Venture Round - Forendo Pharma

Venture Round - Forendo Pharma

Investment Firm

Overview

Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.

Announced Date

Sep 05, 2018

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

Vesalius Biocapital Partners

Vesalius Biocapital Partners

Vesalius Biocapital Partners is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

6

Investor Name
Participant InvestorM Ventures
Participant InvestorInnovestor
Participant InvestorVesalius Biocapital Partners
Participant InvestorNovartis Venture Fund
Participant InvestorNovo Holdings

Round Details and Background

Forendo Pharma raised $4653820 on 2018-09-05 in Venture Round

Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 19, 2018
Debt Financing - Forendo Pharma
1-3.7M
Sep 05, 2018
Venture Round - Forendo Pharma
6-4.7M
Jul 18, 2019
Venture Round - Forendo Pharma
5-5.6M
Oct 22, 2014
Series A - Forendo Pharma
5-15.2M

Recent Activity

There is no recent news or activity for this profile.